Bernstein Cuts Lumentum Target to $635 While Keeping the Faith — and the Marvell Math Cuts Both Ways

Bernstein analyst Daniel Zhu trimmed his price target on Lumentum from $900 to $635 on Wednesday while reaffirming his Outperform rating — a move that says far more about AI-sector multiples than about the optical networking specialist's underlying business.

The distinction matters. Zhu attributes the recent slide across the network equipment makers he covers to compressed valuations rather than downgraded earnings estimates. All five companies in the group that have already reported beat consensus with their guidance, and Zhu left his own forecasts untouched. For Lumentum, that means the lower target still sits alongside a positive recommendation: the operating story holds, but a fuller recovery in the share price depends on investors once again accepting richer multiples.

Zhu concedes he was too optimistic in the near term and warns a complete rebound could take time. He sees room for a technical countermove but few catalysts before January. On AI demand itself, his view remains constructive — he reads weaker annualized AI lab revenue in September as a function of pricing swings rather than a structural slowdown, noting that October revenue came in stronger while token volume growth stayed robust.

A quarter that backs the bull case

Lumentum's own numbers, released roughly a week ago, give the thesis something concrete to stand on. Revenue for the first quarter of fiscal 2027 climbed 136.5% year over year to $1.26 billion, with earnings per share of $4.57 clearing both the company's own guidance range and the $4.22 analyst consensus. Guidance for the following quarter also topped the reported market consensus.

Profitability is doing heavy lifting in the optimistic reading. The adjusted operating margin reached 42.3% in the reported quarter — a figure that gains weight if Lumentum can keep expanding the top line without surrendering that earning power. CEO Michael Hurlston made the case for durability in a CNBC interview on Friday, walking through how the shift from electrical to optical technology is propelling growth. If that transition keeps showing up in results, the sector tailwind becomes a supplement to an operationally grounded story rather than a crutch.

The stock certainly enjoyed the ride that day, gaining 6.6% as semiconductor and AI names recovered. Reports credited the rebound in Marvell and Lumentum's business outlook as additional support.

Two brokerages, two readings of the same deal

Raymond James took a decidedly more aggressive stance, upgrading Lumentum to Strong Buy from Outperform on November 2 and lifting its target to $1,328. The firm pointed to the planned Marvell transaction and argued the market's reaction had been overdone.

That transaction, agreed roughly a week ago, is an all-stock affair: 4.5 Marvell shares for each Lumentum share, with closing expected in the first half of 2028 subject to regulatory approvals. The structure creates a second dependency that investors cannot ignore. Because the consideration is paid in paper, its economic value moves with Marvell's share price — a rising Marvell lifts the effective offer, while weakness there erodes it. According to reports, Marvell's recovery on Friday narrowed the discount to the planned exchange ratio.

So the bull case now rests on two connected variables rather than one. Lumentum's revenue momentum and its ability to defend that 42.3% margin must hold up against guidance, and Marvell's equity must hold up as well. The bear case is simply the mirror image: fading sector tailwinds paired with a softer Marvell quote would apply pressure from both directions at once.

The next real test is operational — delivery against the quarterly guidance already on the table. Further confirmed progress on the takeover could move the valuation too. Until then, Bernstein's trimmed target and Raymond James's upgraded one frame the same debate: what Lumentum earns, and what Marvell's shares are worth when the bill comes due.